HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line

This HeLa cell line is stably transfected with the dual-gene promotor pCDH-CMV-MCS-EF1-copGFP vector without carrying a gene of interest.

Contributors

Inventor Institute
Peter Bradding ; Harvinder Virk University of Leicester
Cat. #: 160703
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Research Fields: Neurobiology
Product description: This cell line is a negative control for the TRPA1 and TRPM2 cell lines developed by Prof Peter Bradding and Dr Harvinder Virk at University of Leicester (see Related tab). This HeLa cell line is stably transfected with the dual-gene promotor pCDH-CMV-MCS-EF1-copGFP vector without carrying a gene of interest.
Conditional: No
Parental cell line: HeLa cervical cancer cell line
Format: Frozen
Shipping conditions: Dry ice
References:

Virk et al. 2019. Sci Rep. 9(1):18500. PMID: 31811235.

Related Tools for Cell lines

Cat. # Tool Name
151014 MCF7 AREc32 Cell Line Key Info View Tool
151445 1-7HB2 Cell Line Key Info View Tool
151630 PDVC57B Cell Line Key Info View Tool
151655 FLYA-13 Cell Line Key Info View Tool
151665 MEF PKCe KO Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.